DrugPatentWatch Database Preview
Drugs in Development Information for D-Proline
What is the drug development status for D-Proline?
D-Proline is an investigational drug.
There have been 4 clinical trials for D-Proline.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2014.
The most common disease conditions in clinical trials are Polycythemia Vera, Polycythemia, and Leukemia, Myeloid. The leading clinical trial sponsors are AOP Orphan Pharmaceuticals AG, Deutsche Krebshilfe e.V., Bonn (Germany), and Fondazione per la Ricerca Ospedale Maggiore.
There are two hundred US patents protecting this investigational drug and two international patents.
Summary for D-Proline
| US Patents | 200 |
| International Patents | 2,772 |
| US Patent Applications | 281 |
| WIPO Patent Applications | 130 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2014-11-01) |
| Vendors | 86 |
Recent Clinical Trials for D-Proline
| Title | Sponsor | Phase |
|---|---|---|
| ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission | AOP Orphan Pharmaceuticals AG | Phase 2 |
| ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission | Deutsche Krebshilfe e.V., Bonn (Germany) | Phase 2 |
| ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission | Philipps University Marburg Medical Center | Phase 2 |
Clinical Trial Summary for D-Proline
Top disease conditions for D-Proline
Top clinical trial sponsors for D-Proline
US Patents for D-Proline
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| D-Proline | Start Trial | Novel peptidyl carbamate inhibitors of the enzyme elastase | University of Kentucky Research Foundation (Lexington, KY) | Start Trial |
| D-Proline | Start Trial | Bis(benzylpyrrolidine) derivatives as dopamine agonists | Syntex (U.S.A.) Inc. (Palo Alto, CA) | Start Trial |
| D-Proline | Start Trial | Bis(benzylpyrrolidine) derivatives useful for treating congestive heart failure and acute renal failure | Syntex (U.S.A.) Inc. (Palo Alto, CA) | Start Trial |
| D-Proline | Start Trial | Process for hair growth | Toyama Chemical Co., Ltd. (Tokyo, JP) | Start Trial |
| D-Proline | Start Trial | Arylsulfonamido-substituted hydroxamic acids | Ciba-Geigy Corporation (Ardsley, NY) | Start Trial |
| D-Proline | Start Trial | Arylsufonamido-substituted hydroxamic acids | Ciba-Geigy Corporation (Tarrytown, NY) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for D-Proline
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| D-Proline | Australia | 4511089 | 2008-10-27 | Start Trial |
| D-Proline | Australia | 629259 | 2008-10-27 | Start Trial |
| D-Proline | Canada | 2001629 | 2008-10-27 | Start Trial |
| D-Proline | European Patent Office | 0367514 | 2008-10-27 | Start Trial |
| D-Proline | European Patent Office | 0396709 | 2008-10-27 | Start Trial |
| D-Proline | Japan | H03503055 | 2008-10-27 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
